Stenocare AS Delivered Products To Its 5 Markets During Q4 2022 Corresponding To Net Sales Of 2.8m DKK And Is On Track For Its Sales Expectations For 2023 In The Range Of 15-20m DKK
PRESS RELEASE STENOCARE entered three new countries during 2022, and thereby expanded their market presence to five countries with prescription-based...
Read more